Over 200 Institutions Research Two Companies, Electronics Component Industry Most Favored
The trend of institutional research is increasingly resembling a collective unconscious carnival. This week, 222 A-share listed companies were swarmed by institutions, yet upon reviewing the results, fewer than 30% posted positive returns—this data itself carries a touch of irony: immense manpower and resources were spent on "research," yet most of the time, they failed to even match the market average. Fuxin Technology stood out with a nearly 70% surge in a week, pushing its stock price to an a
Analysis
The trend of institutional research is increasingly resembling a collective unconscious carnival. This week, 222 A-share listed companies were swarmed by institutions, yet upon reviewing the results, fewer than 30% posted positive returns—this data itself carries a touch of irony: immense manpower and resources were spent on "research," yet most of the time, they failed to even match the market average. Fuxin Technology stood out with a nearly 70% surge in a week, pushing its stock price to an all-time high. Names like Labtech and Zhongjie Precision also rose over 20%. However, if you think carefully, how much of this rally is truly based on fundamental company performance? Or is it the old trick of institutions propping each other up and chasing highs while dumping lows? The electronic components sector continues to dominate popularity, but the extent of speculative sentiment mixed in is something even the participants themselves are well aware of.
Jerry Co. and Dajin Heavy Industry were crowded by over 200 institutions, with a scene as bustling as a market clearance sale. Institutional investors were supposed to be calm and rational, but now they resemble "hounds chasing after a scent," latching onto whatever is hot and swarming wherever prices are rising. Names like Ganfeng Lithium and Salt Lake Industry also filled research lists of over 50 institutions. This seemingly reflects market interest in new energy and materials sectors, but it also hides deeper anxiety: in the volatile A-share market, institutions struggle to find reliable anchors and can only seek strength in numbers. Report after report was written, meeting after meeting was held—but how much of this was genuinely aimed at understanding company value, and how much was merely following the crowd, ticking boxes for KPIs? This superficial busyness contributes minimally to investment decisions and may even fuel new bubbles.
Even more pointedly, this "research craze" has distorted market signals. Institutions label it as "value discovery," but in practice, it often becomes a prelude to price manipulation—first research, then hype, and finally quiet exit, leaving retail investors stranded at high prices. Look at those stocks that rose over 10%, such as Andeli and Longyuan Technology: behind these names, is it solid earnings support, or a short-term game of institutional speculation? The electronic components sector is being pursued largely due to expectations of technological upgrades, but don’t forget that this industry is cyclical and prone to valuation bubbles. Institutions often swarm research after rallies have already begun, rather than digging into potential early on. This hindsight-driven pattern is hard not to criticize.
Ultimately, the distortion of institutional research reveals the restlessness of current investment culture. Everyone is obsessed with "finding hot spots" and "following major players," overlooking the most basic due diligence: deeply understanding a company’s moat and long-term profit logic. The volume of research has surged, but quality is concerning—reports are filled with clichés and lack independent insights. Perhaps someone should ask: when research becomes a social activity, how much sincerity remains in investing? Behind stock price fluctuations, is it genuine industrial growth, or a collective play directed by institutions? Fuxin Technology’s surge is tempting, but those chasing highs should remain vigilant—historical peaks often mark concentration points of risk. As for those overlooked research stocks, they might harbor undervalued opportunities, but unfortunately, the market always favors noise.
Disclaimer: The above content is generated by AI and is for reference only.